C.M. Bidwell & Associates’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-30
| Closed | -$49 | – | 472 |
|
|
2024
Q4 | $49 | Hold |
30
| – | – | ﹤0.01% | 484 |
|
|
2024
Q3 | $105 | Hold |
30
| – | – | ﹤0.01% | 498 |
|
|
2024
Q2 | $98 | Hold |
30
| – | – | ﹤0.01% | 473 |
|
|
2024
Q1 | $220 | Hold |
30
| – | – | ﹤0.01% | 474 |
|
|
2023
Q4 | $112 | Hold |
30
| – | – | ﹤0.01% | 486 |
|
|
2023
Q3 | $64 | Hold |
30
| – | – | ﹤0.01% | 517 |
|
|
2023
Q2 | $143 | Sell |
30
-24,578
| -100% | -$117K | ﹤0.01% | 502 |
|
|
2023
Q1 | $140K | Buy |
24,608
+24,479
| +18,976% | +$140K | 0.11% | 174 |
|
|
2022
Q4 | $1.3K | Buy |
129
+99
| +330% | +$999 | ﹤0.01% | 473 |
|
|
2022
Q3 | $1K | Hold |
30
| – | – | ﹤0.01% | 454 |
|
|
2022
Q2 | $1K | Hold |
30
| – | – | ﹤0.01% | 461 |
|
|
2022
Q1 | $1K | Buy |
+30
| New | +$1K | ﹤0.01% | 499 |
|